29
Participants
Start Date
August 23, 2018
Primary Completion Date
August 20, 2022
Study Completion Date
August 31, 2025
PD-1 antibody + cox inhibitor
"BAT1306 100mg /pembrolizumab 200mg on day 1 + aspirin 200mg oral (celebrex 400mg oral when there is contraindication to aspirin) on day 1-21 every three weeks~Contraindication to aspirin :~Allergic or intolerance to aspirin; With peptic ulcers; With hemophilia or other bleeding tendencies; Have the gentic disease glucose-6 phosphate dehydrogenase deficiency."
RECRUITING
Gastrointestinal Hospital, Sun Yat-sen University, Guangzhou
RECRUITING
The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou
Sun Yat-sen University
OTHER